Glaxosmithkline Intellectual Property Development Limited
Registered as GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED. Company number 08283222. 6 payment practices reports on file, the latest for the period ending 30 June 2026, filed 23 July 2026.
43days on average to pay
- Within 30 days
- 31 to 60 days
- Over 60 days
In the reporting period from 1 January 2026 to 30 June 2026, Glaxosmithkline Intellectual Property Development Limited reported that it took an average of 43 days to pay its suppliers' invoices. It paid 45% of invoices within 30 days, 20% in 31 to 60 days and 35% after more than 60 days. It said 16% of invoices were not paid within the agreed terms.
That average is faster than 25% of the 6,220 companies whose latest report covers a period ending since May 2025. A year earlier, in the period to 30 June 2025, the average was 52 days, so it is 9 days faster now.
Average days to pay, report by report
Bars are labelled with the month the period ended. The dashed line marks 30 days.
Every report filed
| Period | Filed | Average days | Within 30 days | 31 to 60 | Over 60 | Not within terms | Source |
|---|---|---|---|---|---|---|---|
| Jan to Jun 2026 | 23 Jul 2026 | 43 | 45% | 20% | 35% | 16% | Report |
| Jul to Dec 2025 | 27 Jan 2026 | 52 | 42% | 45% | 13% | 9% | Report |
| Jan to Jun 2025 | 29 Jul 2025 | 52 | 29% | 33% | 38% | 11% | Report |
| Jul to Dec 2024 | 31 Jan 2025 | 52 | 36% | 14% | 50% | 11% | Report |
| Jan to Jun 2024 | 30 Jul 2024 | 30 | 64% | 15% | 21% | 11% | Report |
| Jul to Dec 2023 | 30 Jan 2024 | 25 | 74% | 26% | 0% | 3% | Report |
Source: the company's filings on Check payment practices. Contains public sector information licensed under the Open Government Licence v3.0. Figures are as filed. We do not change them.